Systematic screening for occult cancer in elderly patients with venous thromboembolism: A prospective study

Internal Medicine Journal

Volumn 41, Issue 11, 2011, Pages 769-775

  Rieu, V ^a   Chanier, S ^b   Philippe, P ^a   Ruivard, M ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b CENTRE HOSPITALIER   (France)

Author keywords

Cancer; Elderly; Venous thromboembolism

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; COLON ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; THORAX RADIOGRAPHY; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 81255176138     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02448.x     Document Type: Article

References (39)

1. Emmerich J. Epidémiologie de la thrombose veineuse. Bull Acad Nat Med 2003; 187: 19-33.
2. Oger E. Incidence of venous thromboembolism: a community based study in western France. Thromb Haemost 2003; 83: 657-60.
3. Hansson PO. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med 1997; 157: 1665-70.
4. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: 14-8.
5. Nordström M. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-60.
6. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395-403.
7. Ninet J, Coppéré B. Epidémiologie: facteurs de risque de la maladie thromboembolique veineuse. Maladie thromboembolique veineuse (Masson) 1995; Chapter 2: 11-38.3.
8. Lee AY, Levine MN. Venous thromboembolism and cancer. Risks and outcomes. Circulation 2003; 107: I17-21.
9. Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.
10. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
11. Saba HI, Khalil FK, Morelli GA, Foulis PR. Thromboembolism preceding cancer: a correlation study. Am J Hematol 2003; 72: 109-14.
12. Hettiarachchi RJK, Lok J, Prins MH, Büller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis, incidence, risk indicators and diagnosis. Cancer 1998; 83: 180-5.
13. Nordström M, Lindblad B, Bergqvist D, Kjellström T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994; 308: 891-4.
14. Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer. Semin Thromb Hemost 1999; 25: 131-6.
15. Polite BN, Lamont EP. Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case control study of medicare beneficiaries. Cancer 2006; 106: 923-30.
16. Prandoni P, Lensing AW, Büller HR, Cogo A, Prins MH, Cattelan AM etal. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
17. Chraibi S, Bennis A, Kemmou O. Deep venous thrombosis and occult cancer. Ann Cardio Angiol 1997; 46: 145-9.
18. Piccioli A, Prandoni P. Screening for occult cancer in patients with idiopathic venous thromboembolism: yes. J Thromb Haemost 2003; 1: 2271-2.
19. Grenard AS, Mahé I, Tourde V, Bergmann JF. [An aetiological survey of venous thromboembolic disease. What examinations for which patients? 104 observations. Presse Med 2003; 32: 1310-6 (in French).
20. Prandoni P, Lensing AW. Recurrent venous thromboembolism and bleeding complication during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-8.
21. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-10.
22. Piccioli A, Lensing AWA, Prins MH, Falanga A, Scannapieco GL, Ieran M etal. Prandoni P for the SOMIT investigators group. Extensive screening for occult malignancy disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2004; 2: 884-9.
23. Mandala M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R etal. on the behalf of the working group AIOM. Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM). Crit Rev Oncol Hematol 2006; 59: 194-204.
24. Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008; 149: 323-33.
25. Trujillo-Santos J, Prandoni P, Rivron-Guillot K, Roman P, Sanchez R, Tiberio G etal. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry. J Thromb Haemost 2008; 6: 249-50.
26. Ahmed Z, Mohyuddin Z. Deep venous thrombosis as a predictor of cancer. Angiology 1996; 47: 261-5.
27. Rance A, Emmerich J, Guedj C, Fiessinger JN. Occult cancer in patients with bilateral deep-vein thrombosis. Lancet 1997; 350: 1448-9.
28. Kazmers A, Groehn H, Meeker C. Do patients with acute deep vein thrombosis have fever? Am Surg 2000; 66: 598-601.
29. Aburahma AF, Saidy S. Deep vein thrombosis as a probable cause of fever of unknown origin. W V Med J 1997; 93: 368-70.
30. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003; 163: 545-51.
31. Bucek RA, Reiter M, Quehenberger P. C reactive protein in diagnosis of deep vein thrombosis. Br J Haematol 2002; 119: 385-9.
32. Korte WC, Wuillemin WA, Caliezi C, Riesen WF. CRP measured by a high sensitivity assay correlates with clinical probability (Wells score) testing for deep venous thrombosis. Thromb Haemost 2004; 91: 841-2.
33. Enguidanos MJ, Todoli JA, Saro E, Salvador G, Villar J, Gómez-Biedma S etal. [Usefulness of the tumor markers in the diagnosis of idiopathic deep venous thrombosis associated cancer. An Med Inetrna 2002; 19: 561-6 (in Spanish).
34. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with thromboembolism. N Engl J Med 2000; 343: 1847-50.
35. Travade P, Tournilhac O etal. Leucémie Lymphoïde chronique. Encycl Med Chir Hématologie, 2000; 13-013-B20: 12.
36. Bastounis EA, Karayiannakis AJ, Makri GG, Alexiou D, Papalambros EL. The incidence of occult cancer in patient with deep venous thrombosis: a prospective study. J Intern Med 1996; 239: 153-6.
37. Cornuz J, Pearson SD, Creager MA, Cook EF, Goldman L. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med 1996; 125: 785-93.
38. Monreal M, Lensing AWA, Prins MH, Bonet M, Fernández-Llamazares J, Muchart J etal. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary. J Thromb Haemost 2004; 2: 876-81.
39. Bura A, Cailleux N, Bienvenu B, Léger P, Bissery A, Boccalon H etal. Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2004; 2: 441-4.